Tag: dna sequence

Whole Genome Sequencing Is Poised for Clinical Use

CEO SUMMARY: Pathologists and clinical lab managers interested in following the advances in use of whole human genome sequencing for clinical purposes should follow the money. Within weeks of obtaining FDA clearance for its MiSeqDx system and reagents, Illumina had inked major agreements with Quest Diagnostics Incorporated and Laboratory Corporation of America. Both national lab

View Article

Exome Sequencing Next “Big Thing” for Diagnosis

CEO SUMMARY: For disease diagnostics, exome sequencing is not yet routine, but geneticists are getting close. Using this technology, researchers read those parts of the human genome where about 85% of disease-causing mutations reside. By looking only at the regions that encode proteins—the workhorse machinery of the cell—researchers identify dis- ease causes much faster than

View Article

GHSU Graduates Med Techs Using Distance Training

CEO SUMMARY: Many clinical labs experiencing a shortage of trained medical laboratory scientists (MLS) in their city continue to overlook how the use of distance training programs could help them attract and retain top-performers. Leaders of the clinical laboratory scientist (CLS) distance training program at Georgia Health Sciences University (GHSU) say distance students are enthusiastic

View Article

Whole Genome Sequencing: Is It Ready for Prime Time?

CEO Summary: Pathologists at Beth Israel Deaconess Medical Center in Boston, Massachusetts, in a collaboration with GenomeQuest, Inc., will produce whole human genome sequences of patient tumors and other specimens. These whole genome sequences will be studied to learn what diagnostic, therapeutic, and prognostic information they contain. GenomeQuest CEO Richard Resnick discusses what is required

View Article

“January 28, 2002 Intelligence: Late Breaking Lab News”

It may be a sign of change in how at least one national managed care company is willing to contract for laboratory services. During the last four weeks, UnitedHealthcare signed agreements with Dynacare, Inc. and Bio-Reference Laboratories, Inc. (BRLI). Dynacare operates labs in 21 states while BRLI’s core market is Greater New York City. UnitedHealthcare

View Article

Beckman Coulter’s Strategy Reflects Consolidation Trends

CEO SUMMARY: Rapid changes to the clinical laboratory industry had equally profound impact upon the major diagnostic companies. At Beckman Coulter, Inc., market forces triggered a decade of acquisitions and internal consolidation.The company looks very different today than it did ten years ago. Here’s a look at how Beckman Coulter views the near future for

View Article